Last checked at 27 Jan 2017 11:27
27 January 2017
CVS Group plc
("CVS" or the "Company")
Exercise of Options, Director/PDMR and PCA Dealing and Total Voting Rights
CVS, one of the UK's leading provider of integrated veterinary services for small and large animals, announces that, Nick Perrin, Finance Director of the Company, and certain employees of the Company have exercised options at 215 pence per share over an aggregate of 186,189 ordinary shares of 0.2 pence each in the Company (the "SAYE Shares"), in connection with the Company's 2013/2016 Save As You Earn Scheme.
The 186,189 SAYE Shares comprise 92,281 Ordinary Shares issued on 13 January 2017, 58,503 Ordinary Shares issued on 19 January 2017 and 35,405 Ordinary Shares issued on 26 January 2017.
Nick Perrin, exercised options over 4,186 ordinary shares of 0.2p each in the Company ("Ordinary Shares"), subsequent to which on 27 January 2017, the Company was notified that on that date, Nick Perrin sold 1,950 Ordinary Shares at a price of 1,042p per Ordinary Share. Also on 27 January 2017, Mr Perrin transferred 1,950 Ordinary Shares to his wife, Julia Therese Perrin, a Person Closely Associated ("PCA") of Mr Perrin. On 27 January 2017, Mrs Perrin subsequently sold 1,950 Ordinary Shares at a price of 1,042p per Ordinary Share.
Mr Perrin's total interest in the Company is now 28,286 Ordinary Shares, representing 0.04 per cent. of the total voting rights of the Company.
The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of the SAYE Shares has been satisfied via the Company's block listing which was announced on 19 December 2016.
Following issue of the SAYE Shares, the Company's total issued share capital will consist of 63,829,560 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of SAYE Shares, the total number of voting rights in the Company is 63,829,560. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.
Contacts:
CVS Group plc Simon Innes, Chief Executive Nick Perrin, Finance Director
| Tel: 01379 644 288
|
N+1 Singer (Nominated Adviser & Broker) Aubrey Powell Liz Yong James Hopton | Tel: 020 7496 3000
|
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Nick Perrin | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Finance Director | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| CVS Group plc | ||||
b)
| LEI
| 213800J41XDQ2NX48O05 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 0.2 pence each
GB00B2813827
| ||||
b)
| Nature of the transaction
| (i) Option Exercise (ii) Sale of Ordinary Shares by a PDMR (iii) Transfer of Ordinary Shares by a PDMR to a PCA | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
n/a | ||||
e)
| Date of the transaction
| (i) 26 January 2017 (ii) 27 January 2017 (iii) 27 January 2017 | ||||
f)
| Place of the transaction
| (i) Outside of trading venue (ii) London Stock Exchange (XLON) (iii) Outside of trading venue | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Julia Therese Perrin | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| PCA of Nick Perrin | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| CVS Group plc | ||||
b)
| LEI
| 213800J41XDQ2NX48O05 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 0.2 pence each
GB00B2863827
| ||||
b)
| Nature of the transaction
| (i) Receipt of transfer of Ordinary Shares by a PDMR to a PCA (ii) Sale of Ordinary Shares by a PCA | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
n/a | ||||
e)
| Date of the transaction
| (i) 27 January 2017 (ii) 27 January 2017
| ||||
f)
| Place of the transaction
| (i) Outside of trading venue (ii) London Stock Exchange (XLON)
| ||||